Rabeprazole Domperidone in pharma franchise in Nagaland

Rabeprazole Domperidone in PCD pharma franchise in Chandigarh

Rabeprazole Domperidone in top pharma company in Chennai

Rabeprazole Domperidone in pcd pharma supplier in Maharashtra

Rabeprazole Domperidone in phama franchise company in india
Rabeprazole Domperidone in phama distributor in Kanpur

Ribziff DSR 40 capsule

Composition : Rabeprazole 40mg (EC) + Domperidone 30mg (SR) Capsule

Dosage Form : Capsule

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹210/-

Please Contact For Best Price

Ribziff DSR 40 capsule is a highly effective and widely prescribed medication that offers a comprehensive solution for a range of gastrointestinal disorders. The formulation combines the potent acid-suppressing power of Rabeprazole (40mg, EC) with the prokinetic benefits of Domperidone (30mg, SR). Rabeprazole, a proton pump inhibitor, provides long-lasting relief by significantly reducing the production of stomach acid, while the sustained-release Domperidone improves gut motility, preventing acid reflux and alleviating associated symptoms like bloating, nausea, and discomfort. This dual-action mechanism makes Ribziff DSR 40 an ideal choice for the effective and long-term management of conditions like GERD, gastritis, and peptic ulcers.

The gastroenterology segment of the Indian pharmaceutical market is a high-volume, high-demand sector with consistent and predictable growth. The rising prevalence of stomach and digestive issues, driven by modern lifestyles and stress, ensures a continuous and robust need for medicines like Ribziff DSR 40. This makes it a strategic product for any distributor seeking a stable and profitable business. The ubiquity of gastric problems means that this capsule is a fast-moving product with a wide prescription base from general physicians and specialists alike, providing a reliable source of revenue and a strong foundation for your business.

Read More

About the Product

Ribziff DSR 40 capsule is a highly effective and widely prescribed medication that offers a comprehensive solution for a range of gastrointestinal disorders. The formulation combines the potent acid-suppressing power of Rabeprazole (40mg, EC) with the prokinetic benefits of Domperidone (30mg, SR). Rabeprazole, a proton pump inhibitor, provides long-lasting relief by significantly reducing the production of stomach acid, while the sustained-release Domperidone improves gut motility, preventing acid reflux and alleviating associated symptoms like bloating, nausea, and discomfort. This dual-action mechanism makes Ribziff DSR 40 an ideal choice for the effective and long-term management of conditions like GERD, gastritis, and peptic ulcers.

The gastroenterology segment of the Indian pharmaceutical market is a high-volume, high-demand sector with consistent and predictable growth. The rising prevalence of stomach and digestive issues, driven by modern lifestyles and stress, ensures a continuous and robust need for medicines like Ribziff DSR 40. This makes it a strategic product for any distributor seeking a stable and profitable business. The ubiquity of gastric problems means that this capsule is a fast-moving product with a wide prescription base from general physicians and specialists alike, providing a reliable source of revenue and a strong foundation for your business.

Common side effects may include headache, dizziness, dry mouth, and gastrointestinal disturbances such as diarrhea or constipation. In rare cases, more serious side effects may occur, and patients should consult their healthcare provider if they experience any unusual symptoms.

Ribziff DSR 40 is indicated for the treatment of gastroesophageal reflux disease (GERD), peptic ulcers, and other acid-related disorders, as well as for the management of nausea and vomiting.

Consult a healthcare professional before use, especially if you are pregnant, nursing, or have pre-existing medical conditions.

Store Ribziff DSR 40 capsules in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children.

Get in Touch